About Symple Surgical
Symple Surgical is a Healthcare company based in Menlo Park (United States) founded in 2012. It operates as a microwave ablation is developed for hypertension treatment. Symple Surgical has raised $3.4 million across 5 funding rounds from investors including HHS and Moonshot Arizona. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include ReCor Medical, Ablative Solutions, Brattea, Kona Medical and Autonomix and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Symple Surgical is a medical devices company developing novel therapeutic using controlled Microwave Ablation. Their first product offering is the DirectAblate Renal Denervation System which is used for the treatment of resistant hypertension. It delivers microwave thermal energy directly to the precise location of overactive sympathetic nerves while minimizing thermal exposure to non-targeted tissue.
- Headquarters Menlo Park, United States
- SectorsHealthcare
- Website symplesurgical.com
- Social LinkedIn X
- Total Equity Funding$3.4M (USD)
in 5 rounds
- Latest Funding Round$366K (USD), Grant
Sep 2021
- InvestorsHHS
& 1 more
Funding Insights of Symple Surgical
Symple Surgical has successfully raised a total of $3.4M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $366 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.4M
- Total Rounds 5
- Last Round Grant — $366,005
- First Round $1.9M
(Nov 2013)
- Investors Count 2
All 5 funding rounds of Symple Surgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Symple Surgical
Symple Surgical has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Moonshot Arizona.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Moonshot Arizona is focused on supporting rural entrepreneurship and innovation. | 2001 | moonshotaz.com | Flagstaff, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Symple Surgical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Symple Surgical
1 people are tracked at Symple Surgical (1 in team).
| Name | Role | Group |
|---|---|---|
Bryce Igo | R&D Engineer | Team |
Complete people profiles for Symple Surgical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Symple Surgical
3 dated milestones of Symple Surgical across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Symple Surgical is founded.
- Funding First funding round of $1.9M.
- Funding Latest funding round, Grant, of $366K.
Competitors of Symple Surgical
Symple Surgical has 9 listed competitors in our database, 8 of them funded. They include ReCor Medical, Ablative Solutions, Brattea, Kona Medical and Autonomix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| recormedical.com | 2009 | Palo Alto, United States | $15M | 93 | Ultrasound-based renal denervation is applied for hypertension treatment. | |
| ablativesolutions.com | 2011 | Kalamazoo, United States | $293.24M | 24 | A catheter-based renal denervation system for hypertension treatment is developed. | |
| brattea.com | 2013 | Xuhui, China | $15.2M | – | Developer of a medical device for the treatment of hypertension | |
| konamedical.com | 2009 | Issaquah, United States | $73.66M | 39 | Provides ultrasound-based renal denervation solutions for hypertension treatment. | |
| autonomix.com | 2014 | The Woodlands, United States | $8.2M | – | Minimally invasive neural monitoring and treatment devices are developed. | |
| vessixvascular.com | 2003 | Laguna Hills, United States | $27.7M | 10 | Thermoplasty technology for occlusive peripheral vascular diseases is developed. | |
| kalosmedical.com | 2015 | Suwon-si, South Korea | – | – | Developer of medical devices for the treatment of hypertension & other chronic diseases | |
| maya-medical.com | 2010 | Campbell, United States | $6.92M | – | Catheter based ablative technology for renal denervation to treat hypertension | |
| verve-medical.com | 2011 | Santa Barbara, United States | $3.63M | – | Renal denervation treatments for hypertension are developed by Verve Medical. |
Detailed competitors of Symple Surgical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Symple Surgical (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Symple Surgical
Complete news archive for Symple Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Symple Surgical
Symple Surgical was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Symple Surgical is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Symple Surgical is a funded company, having raised a total of $3.4M across 5 funding rounds to date. The company's 1st funding round was a Series A of $1.9M, raised on Nov 2013.
Symple Surgical is a medical devices company developing novel therapeutic using controlled Microwave Ablation. Their first product offering is the DirectAblate Renal Denervation System which is used for the treatment of resistant hypertension. It delivers microwave thermal energy directly to the precise location of overactive sympathetic nerves while minimizing thermal exposure to non-targeted tissue.
Symple Surgical's top competitors include ReCor Medical, Autonomix and Ablative Solutions.
Symple Surgical has 2 investors. Key investors include HHS, and Moonshot Arizona.